Molecular diagnosis of genetic dyslipidaemias by next generation sequencing


Poster presented at the 90th European Atherosclerosis Society Congress. Hybrid congress (virtual and in Milan, Italy) on 22-25 May 2022


B. Miranda, A. Alves, M. Bourbon
Atherosclerosis, vol. 355, 2022 Aug 1, pp. 148-149


Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Miranda, B., Alves, A., & Bourbon, M. (2022). Molecular diagnosis of genetic dyslipidaemias by next generation sequencing. In Atherosclerosis (Vol. 355, pp. 148–149). https://doi.org/10.1016/j.atherosclerosis.2022.06.653


Chicago/Turabian   Click to copy
Miranda, B., A. Alves, and M. Bourbon. “Molecular Diagnosis of Genetic Dyslipidaemias by next Generation Sequencing.” In Atherosclerosis, 355:148–149, 2022.


MLA   Click to copy
Miranda, B., et al. “Molecular Diagnosis of Genetic Dyslipidaemias by next Generation Sequencing.” Atherosclerosis, vol. 355, 2022, pp. 148–49, doi:10.1016/j.atherosclerosis.2022.06.653.


BibTeX   Click to copy

@conference{b2022a,
  title = {Molecular diagnosis of genetic dyslipidaemias by next generation sequencing},
  year = {2022},
  month = aug,
  day = {1},
  journal = {Atherosclerosis},
  pages = {148-149},
  volume = {355},
  doi = {10.1016/j.atherosclerosis.2022.06.653},
  author = {Miranda, B. and Alves, A. and Bourbon, M.},
  month_numeric = {8}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in